Simplex Trading, LLC Selecta Biosciences Inc Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$1.02 - $1.23 $1,106 - $1,334	-1,085 Reduced 83.85%	209 $0
Q2 2023 Aug 04, 2023	SELL	$1.04 - $1.4 $35,218 - $47,409	-33,864 Reduced 96.32%	1,294 $1,000
Q1 2023 Apr 27, 2023	BUY	$1.15 - $1.89 $40,431 - $66,448	35,158 New	35,158 $48,000
Q2 2022 Aug 03, 2022	SELL	$0.67 - $1.4 $5,406 - $11,298	-8,070 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$1.23 - $3.31 $26,159 - $70,397	-21,268 Reduced 72.49%	8,070 $9,000
Q4 2021 Feb 23, 2022	BUY	$2.89 - $4.43 $74,839 - $114,719	25,896 Added 752.35%	29,338 $95,000
Q3 2021 Oct 28, 2021	SELL	$3.36 - $4.62 $1,092 - $1,501	-325 Reduced 8.63%	3,442 $15,000
Q2 2021 Aug 12, 2021	SELL	$2.82 - $5.01 $141,095 - $250,670	-50,034 Reduced 93.0%	3,767 $15,000
Q1 2021 Apr 26, 2021	BUY	$2.92 - $5.07 $125,933 - $218,658	43,128 Added 404.09%	53,801 $243,000
Q4 2020 Feb 02, 2021	BUY	$1.64 - $3.42 $9,616 - $20,054	5,864 Added 121.94%	10,673 $0
Q3 2020 Oct 14, 2020	SELL	$2.18 - $2.84 $176 - $230	-81 Reduced 1.66%	4,809 $0
Q2 2020 Jul 13, 2020	BUY	$1.83 - $4.06 $8,765 - $19,447	4,790 Added 4790.0%	4,890 $13,000
Q1 2020 Apr 29, 2020	BUY	$1.5 - $4.52 $150 - $451	100 New	100 $0
Q2 2019 Jul 26, 2019	SELL	$1.79 - $3.05 $8,858 - $15,094	-4,949 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$1.47 - $3.06 $6,181 - $12,867	4,205 Added 565.19%	4,949 $0
Q4 2018 Jan 16, 2019	SELL	$2.66 - $15.93 $1,925 - $11,533	-724 Reduced 49.32%	744 $1,000
Q3 2018 Oct 23, 2018	SELL	$12.07 - $16.0 $10,175 - $13,488	-843 Reduced 36.48%	1,468 $22,000
Q2 2018 Jul 30, 2018	BUY	$9.36 - $13.25 $11,334 - $16,045	1,211 Added 110.09%	2,311 $30,000
Q1 2018 Apr 26, 2018	BUY	$8.49 - $11.82 $9,339 - $13,002	1,100 New	1,100 $11,000

Others Institutions Holding SELB

# of Institutions

Shares Held

4.67M

Call Options Held

Put Options Held

View Full List

About SELECTA BIOSCIENCES INC

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

More about SELB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account